Activation of cancer cell apoptosis and enhanced ROS levels by the stimulation of the JNK/c‐JUN pathway, anti‐cancerous activity against breast cancer when combined with chemotherapeutic drugs. The gene discussed is JUN; the disease is breast carcinoma.